View in EDS

A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer.

Saved in:
Bibliographic Details
Title: A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer.
Authors: Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Bianchi V; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.; Center for Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Tanyi JL; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Sarivalasis A; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Missiaglia E; Institute of Pathology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Pétremand R; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Benedetti F; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Torigian DA; Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Genolet R; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Michel A; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Mastroyannis SA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Zsiros E; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Tsourti Z; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece., Stevenson BJ; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Iseli C; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Bioinformatics Competence Center, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Levine BL; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Speiser DE; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Gfeller D; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Powell DJ Jr; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., June CH; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Dafni U; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece., Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.; Center for Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland. george.coukos@chuv.ch.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland. george.coukos@chuv.ch.
Source: Nature cancer [Nat Cancer] 2023 Oct; Vol. 4 (10), pp. 1410-1417. Date of Electronic Publication: 2023 Sep 21.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37735588
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bobisse+S%22">Bobisse S</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bianchi+V%22">Bianchi V</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.; Center for Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tanyi+JL%22">Tanyi JL</searchLink>; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Sarivalasis+A%22">Sarivalasis A</searchLink>; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Missiaglia+E%22">Missiaglia E</searchLink>; Institute of Pathology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pétremand+R%22">Pétremand R</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Benedetti+F%22">Benedetti F</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Torigian+DA%22">Torigian DA</searchLink>; Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Genolet+R%22">Genolet R</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Barras+D%22">Barras D</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Michel+A%22">Michel A</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mastroyannis+SA%22">Mastroyannis SA</searchLink>; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zsiros+E%22">Zsiros E</searchLink>; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dangaj+Laniti+D%22">Dangaj Laniti D</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tsourti+Z%22">Tsourti Z</searchLink>; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Stevenson+BJ%22">Stevenson BJ</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Iseli+C%22">Iseli C</searchLink>; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Bioinformatics Competence Center, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Levine+BL%22">Levine BL</searchLink>; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Speiser+DE%22">Speiser DE</searchLink>; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gfeller+D%22">Gfeller D</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bassani-Sternberg+M%22">Bassani-Sternberg M</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Powell+DJ+Jr%22">Powell DJ Jr</searchLink>; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22June+CH%22">June CH</searchLink>; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Dafni+U%22">Dafni U</searchLink>; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Kandalaft+LE%22">Kandalaft LE</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.; Center for Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Harari+A%22">Harari A</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Coukos+G%22">Coukos G</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland. george.coukos@chuv.ch.; Center for Cell Immunotherapy, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland. george.coukos@chuv.ch.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101761119%22">Nature cancer</searchLink> [Nat Cancer] 2023 Oct; Vol. 4 (10), pp. 1410-1417. <i>Date of Electronic Publication: </i>2023 Sep 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101761119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2662-1347 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226621347%22">26621347 </searchLink><i>NLM ISO Abbreviation: </i>Nat Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37735588
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s43018-023-00623-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1410
    Titles:
      – TitleFull: A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bobisse S
      – PersonEntity:
          Name:
            NameFull: Bianchi V
      – PersonEntity:
          Name:
            NameFull: Tanyi JL
      – PersonEntity:
          Name:
            NameFull: Sarivalasis A
      – PersonEntity:
          Name:
            NameFull: Missiaglia E
      – PersonEntity:
          Name:
            NameFull: Pétremand R
      – PersonEntity:
          Name:
            NameFull: Benedetti F
      – PersonEntity:
          Name:
            NameFull: Torigian DA
      – PersonEntity:
          Name:
            NameFull: Genolet R
      – PersonEntity:
          Name:
            NameFull: Barras D
      – PersonEntity:
          Name:
            NameFull: Michel A
      – PersonEntity:
          Name:
            NameFull: Mastroyannis SA
      – PersonEntity:
          Name:
            NameFull: Zsiros E
      – PersonEntity:
          Name:
            NameFull: Dangaj Laniti D
      – PersonEntity:
          Name:
            NameFull: Tsourti Z
      – PersonEntity:
          Name:
            NameFull: Stevenson BJ
      – PersonEntity:
          Name:
            NameFull: Iseli C
      – PersonEntity:
          Name:
            NameFull: Levine BL
      – PersonEntity:
          Name:
            NameFull: Speiser DE
      – PersonEntity:
          Name:
            NameFull: Gfeller D
      – PersonEntity:
          Name:
            NameFull: Bassani-Sternberg M
      – PersonEntity:
          Name:
            NameFull: Powell DJ Jr
      – PersonEntity:
          Name:
            NameFull: June CH
      – PersonEntity:
          Name:
            NameFull: Dafni U
      – PersonEntity:
          Name:
            NameFull: Kandalaft LE
      – PersonEntity:
          Name:
            NameFull: Harari A
      – PersonEntity:
          Name:
            NameFull: Coukos G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2023 Oct
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2662-1347
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Nature cancer
              Type: main
ResultId 1